why choose us

First received: October 27, 2023

Clinical Trial: Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 2 Diabetes Mellitus

Study Type: INTERVENTIONAL


Official Title: Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy

Brief Summary: The investigators initial study opened the way for randomized trials that monitor the effects of acetylcholine (Ach) iontophoresis vasodilators on endothelial nitric oxide synthetase (NOS) to develop a transdermal treatment that is effective, free from systemic adverse effects.

Read more